ブラウザの設定でJava Scriptの使用を有効にしてご利用ください。
出典:Wikipedia
出典:『Wikipedia』 (2011/07/01 15:00 UTC 版)
Safinamide is a candidate drug against Parkinson's disease with multiple methods of action. In 2007, a Phase III clinical trial was started. It is scheduled to run until 2011. The drug will be marketed by Merck-Serono.
Safinamide